2015-11-16T13:41:04-06:00 2014-12-31 Grant Thornton LLP 700 Milam Street Suite 300 Houston TX 77002 990 2014-01-01 760683142 Biohouston Inc % ANN K TANABE BIOH 7138749300 2450 Holcombe Blvd Suite 27G Houston TX 77021 ANN TANABE Chief Executive Officer 8324763600 2015-11-16 true Shannon a Rudisell P00435018 8324763600 2014 2016-04-25 22:37:26Z X Ann K Tanabe 2450 Holcombe Blvd Suite 27G Houston TX 77021 1239358 false X www.biohouston.org X 2001 TX Education of life science by bringing together resources, capabilities, and opportunities to develop the southeast Texas region as a global leader in biotechnology research 22 21 0 21 0 756350 759500 1493099 471738 450 420 -19032 -14981 2230867 1216677 0 0 0 0 1318468 920815 0 0 129918 918062 369067 2236530 1289882 -5663 -73205 661556 502632 214312 128593 447244 374039 X BIOHOUSTON, INC. IS A TEXAS NON-PROFIT CORPORATION WITH THE MISSION OF STIMULATING TECHNOLOGY TRANSFER AND THE COMMERCIALIZATION OF RESEARCH, WHILE BUILDING A CRITICAL MASS OF LIFE SCIENCE COMPANIES. TO ACCOMPLISH THIS GOAL, BIOHOUSTON ESTABLISHED CERTAIN PROGRAMS FOR LIFE SCIENCE COMPANIES. BIOHOUSTON IS SUPPORTED PRIMARILY THROUGH CONTRIBUTIONS FROM ITS MEMBERS, ASSOCIATES, THE PHILANTHROPIC COMMUNITY, REVENUE FROM CONFERENCES AND OTHER EVENTS HELD BY THE ORGANIZATION, AND FROM A CONTRACT TO PROVIDE SERVICES TO THE CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS. false false 224505 120460 Support the regional life science industry through educational conferences and networking meetings; BioHouston hosts two major annual conferences attracting hundreds, breakfast forums, technology transfer meetings, and other meetings to foster entrepreneurship, education, and networking 219640 107036 FOSTERING ENTREPRENEURSHIP in the life science industry in the region 411918 200738 LEVERAGING THE SKILLS OF EXPERTS throughout the world to support the development of products and therapies in Texas 89270 43504 Increase Awareness of life science industry 89270 43504 945333 true true false false false false false false false false true false false false false true true false false false false false false false true false false false false true false false false false false false false false false false false false false false false false false true 11 0 true 0 false false false false false true true false false false false X 22 21 false false false false true true true true true false false true true true true false false true true false X ANN K TANABE 7138749300 2450 HOLCOMBE STE 27G Houston TX 77021 Jacqueline R Northcut CEO & President 40.0 0.0 X X 331180 0 10200 David B McWilliams Chairman of the Board 1.0 0.0 X 0 0 0 John Mendelsohn MD Vice Chairman of the Board 1.0 0.0 X 0 0 0 Bruce Given MD Director 1.0 0.0 X 0 0 0 David W Leebron Director 1.0 0.0 X 0 0 0 Malcolm Gillis Director 1.0 0.0 X 0 0 0 Joe H Cunningham MD Director 1.0 0.0 X 0 0 0 Paul Klotman MD Director 1.0 0.0 X 0 0 0 Daniel J Moore Director 1.0 0.0 X 0 0 0 David L Callender MD Director 1.0 0.0 X 0 0 0 Rathindra N Bose PhD Director 1.0 0.0 X 0 0 0 Mauro Ferrari PhD Director 1.0 0.0 X 0 0 0 Giuseppe N Colasurdo MD Director 1.0 0.0 X 0 0 0 Brett Giroir MD Director 1.0 0.0 X 0 0 0 Robert F Gray Jr Director 1.0 0.0 X 0 0 0 Ronald A DePinho MD Director 1.0 0.0 X 0 0 0 George L McLendon PhD Director 1.0 0.0 X 0 0 0 Neil K Warma Director 1.0 0.0 X 0 0 0 Dan Watkins PhD Director 1.0 0.0 X 0 0 0 Margaret A Boulware Director 1.0 0.0 X 0 0 0 James T Willerson MD Director 1.0 0.0 X 0 0 0 Robert E Wilson Director 1.0 0.0 X 0 0 0 Ann K Tanabe Chief Operating Officer 40.0 0.0 X 183783 0 4865 Jeff Larson VP, Texas Bioalliance 40.0 0.0 X 142500 0 5700 657463 0 20765 3 false true false NONE NONE 0 X 561000 198500 759500 BIOALLIANCE PROGRAM SERVICES 900099 211687 211687 OTHER PROGRAM SERVICES 900099 260051 260051 471738 420 420 0 0 0 0 0 0 7700 198500 22681 -14981 -14981 0 0 0 1216677 471738 -14561 0 0 0 0 514963 360475 77244 77244 0 273407 262650 3004 7753 18866 14912 1920 2034 113579 89773 11561 12245 0 0 365 365 20450 20450 0 0 0 101499 56317 36812 8370 0 26989 18056 4813 4120 6768 6091 677 0 39268 31246 3895 4127 6737 6737 0 95403 83255 12148 159 159 0 4428 3500 451 477 6702 5297 682 723 DUES & SUBSCRIPTIONS 7024 7024 BAD DEBT EXPENSE 53275 53275 1289882 945333 214631 129918 X 122453 99654 280382 280801 51932 72500 186714 42137 0 0 0 0 0 0 0 0 8231 4424 95843 94227 6044 1616 0 0 0 0 0 0 0 0 5800 1500 661556 502632 158113 117740 0 0 56199 10853 0 0 0 0 0 0 0 0 0 0 0 0 214312 128593 X 447244 374039 0 0 0 0 447244 374039 661556 502632 -73205 X false true X true false X X X 8 BAYLOR COLLEGE OF MEDICINE 741613878 02 true 0 0 RICE UNIVERSITY 741109620 02 true 0 0 THE UNIVERSITY OF HOUSTON SYSTEM 746001399 02 true 0 0 THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON 746041411 03 true 0 0 THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 746001118 03 true 0 0 THE UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON 746000949 03 true 0 0 THE METHODIST HOSPITAL RESEARCH INSTITUTE 741180155 03 true 0 0 TEXAS A&M UNIVERSITY 741238434 02 true 0 0 8 true false false false false false false false false false false false false false false true false RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 95843 94227 1616 1616 0 0 X 1239358 22681 22681 1216677 1216677 1312563 22681 22681 1289882 1289882 Sch. D, Part X, Line 2 ASC 740 (FIN 48) Disclosure BioHouston is exempt from federal income tax under Section 501(c)(3) of the Internal Revenue Code and is classified as a public charity under Section 170(b)(1)(A)(vi). It recognizes the impact of an uncertain tax position only if that position is more likely than not of being sustained upon examination by the taxing authority based on the technical merits. BioHouston will account for interest and penalties relating to uncertain tax positions in the current period statement of activities, if necessary. The tax years from 2011 forward are open for examination by the Internal Revenue Service (IRS). BioHouston is a Type I Section 509(a)(3) supporting organization and has requested determination as such from the IRS. Sch. D, Part XI, Line 2d Fundraising Event Expenses $22,681 Sch. D, Part XII, Line 2d Fundraising Event Expenses $22,681 Annual Luncheon 206200 198500 7700 5000 17681 0 206200 198500 7700 5000 17681 22681 -14981 X X X false false false false false false false false false Jacqueline R Northcut CEO & President 331180 0 0 0 0 0 10200 0 0 0 341380 0 0 0 Ann K Tanabe Chief Operating Officer 183783 0 0 0 0 0 4865 0 0 0 188648 0 0 0 Executive Committee Form 990, Part VI, Line 1A The Executive Committee is elected by the board of directors. Members include the Board Chair, Vice Chair, and other directors, as appointed. The Executive Committee has the authority to oversee the day to day operations of the organization with oversight by the full board, and may exercise the full power of the Board except with respect to matters on which the Board has taken action, the Members have taken action, or the Executive Committee is prohibited by applicable law from taking action. Organization Members Form 990, Part VI, Lines 6, 7a, & 7b Organizations described in Sections 501(c)(3) or 170(c)(1) and Sections 509(a)(1) or 509(a)(2) of the Code are eligible to be Members. Members shall be appointed by and may be removed by the board of directors. Members are entitled to vote at elections of directors and on any matter submitted for a vote of Members. Generally directors are elected at the annual meeting of the Members. Any vacancy occurring in the Board may be filled by election at an annual meeting or special meeting of Members called for that purpose. Any director may be removed either for or without cause by the Members. Form 990 Review Process Form 990, Part VI, Line 11b Prior to filing with the IRS, the organizaton's Form 990 is reviewed and approved by the audit committee; a draft of the Form 990 is provided electronically to board members for review prior to filing. Conflict of Interest Policy Monitoring & Enforcement Form 990, Part VI, Line 12c Each director, principal officer, and member of a committee with board delegated powers is required to annually sign a statement that affirms that such person has received a copy of the policy; has read and understands the policy; is in compliance with the policy; and understands that the corporation must engage primarily in activities which accomplish one or more of its tax-exempt purposes. Any identified conflicts are brought to the executive committee or full board of directors for resolution. Officer Compensation Approval Form 990, Part VI, Lines 15a & 15B The Compensation Committee of the Corporation's Board of Directors, all of whom are independent directors, conducts an annual review of the CEO, other officers, and key employees' perfomance and compensation. The review is conducted in executive session. How Documents are made available to the public Form 990, Part VI, Line 19 The corporation makes its governing documents, conflict of interest policy, and financial statements available to the public upon request. Program Service Accomplishments Form 990, Part III, Line 4d Increasing the awareness of the life science industry with the goal of ultimately increasing investment in regional life science companies, attracting experienced managers to local life science companies and attracting life science companies to Texas Employees Reported on W-3 Form 990, Part V, Line 2A ALL EMPLOYEES ARE CONTRACTED THROUGH INSPERITY, AN EMPLOYEE LEASING AGENCY; THEREFORE, BIOHOUSTON HAS NO EMPLOYEES DIRECTLY REPORTED ON A FORM W-3.